• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris.

作者信息

Fenizia Claudio, Moltrasio Chiara, Ottobrini Luisa, Utyro Olga, Genovese Giovanni, Vanetti Claudia, Trabattoni Daria, Marzano Angelo V

机构信息

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Medical Surgical and Health Sciences, University of Trieste, Trieste, Italy.

出版信息

J Invest Dermatol. 2023 Aug;143(8):1601-1604. doi: 10.1016/j.jid.2022.12.023. Epub 2023 Jan 28.

DOI:10.1016/j.jid.2022.12.023
PMID:36716924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9883068/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/614b/9883068/4964675a7c81/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/614b/9883068/4964675a7c81/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/614b/9883068/4964675a7c81/gr1_lrg.jpg

相似文献

1
SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris.利妥昔单抗治疗的寻常型天疱疮患者中SARS-CoV-2疫苗的有效性
J Invest Dermatol. 2023 Aug;143(8):1601-1604. doi: 10.1016/j.jid.2022.12.023. Epub 2023 Jan 28.
2
Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative review.在 COVID-19 大流行期间用利妥昔单抗治疗寻常型天疱疮：一项叙述性综述。
Dermatol Ther. 2021 Jan;34(1):e14405. doi: 10.1111/dth.14405. Epub 2020 Oct 20.
3
Rituximab for COVID-19 Vaccine-Associated Pemphigus Vulgaris.
Am J Ther. 2023;30(6):e544-e546. doi: 10.1097/MJT.0000000000001620. Epub 2023 Mar 7.
4
Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris.评估使用利妥昔单抗治疗寻常型天疱疮患者对 SARS-CoV-2 感染的易感性。
J Dermatolog Treat. 2022 May;33(3):1606-1607. doi: 10.1080/09546634.2020.1870648. Epub 2021 Jan 12.
5
COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigus.COVID 疫苗接种在接受利妥昔单抗治疗的患者中：来自伊朗的两例病例报告及当前知识的综述，特别关注天疱疮。
Dermatol Ther. 2022 Jan;35(1):e15216. doi: 10.1111/dth.15216. Epub 2021 Dec 1.
6
T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris.利妥昔单抗治疗的寻常型天疱疮患者的T细胞记住了新冠病毒。
J Invest Dermatol. 2023 Aug;143(8):1340-1341. doi: 10.1016/j.jid.2023.02.002. Epub 2023 Mar 21.
7
Can rituximab be used in the treatment of pemphigus vulgaris during the COVID-19 pandemic?在 COVID-19 大流行期间，可以用利妥昔单抗治疗寻常型天疱疮吗？
Dermatol Ther. 2021 Jan;34(1):e14647. doi: 10.1111/dth.14647. Epub 2020 Dec 15.
8
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination.新型冠状病毒疫苗接种后寻常型天疱疮严重复发。
J Eur Acad Dermatol Venereol. 2023 Dec;37(12):e1369-e1371. doi: 10.1111/jdv.19414. Epub 2023 Aug 19.
9
Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab.针对接受利妥昔单抗治疗的天疱疮患者的新冠疫苗接种策略
J Am Acad Dermatol. 2021 Apr;84(4):e197-e198. doi: 10.1016/j.jaad.2020.10.075. Epub 2020 Oct 29.
10
Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.接种 SARS-CoV-2 疫苗后发生寻常型天疱疮：1 例新发，2 例严重恶化。
Dermatol Ther. 2022 May;35(5):e15396. doi: 10.1111/dth.15396. Epub 2022 Mar 15.

引用本文的文献

1
Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine.HIV 垂直感染的年轻患者在接种三剂 BNT162b2 mRNA SARS-CoV-2 疫苗后的体液和细胞介导免疫反应。
Front Immunol. 2024 Jan 4;14:1301766. doi: 10.3389/fimmu.2023.1301766. eCollection 2023.
2
Updated Considerations for the Immunopharmacological Aspects of the "Talented mRNA Vaccines".“卓越信使核糖核酸疫苗”免疫药理学方面的最新考量
Vaccines (Basel). 2023 Sep 12;11(9):1481. doi: 10.3390/vaccines11091481.